1.Network Pharmacology and Experimental Verification Unraveled The Mechanism of Pachymic Acid in The Treatment of Neuroblastoma
Hang LIU ; Yu-Xin ZHU ; Si-Lin GUO ; Xin-Yun PAN ; Yuan-Jie XIE ; Si-Cong LIAO ; Xin-Wen DAI ; Ping SHEN ; Yu-Bo XIAO
Progress in Biochemistry and Biophysics 2025;52(9):2376-2392
ObjectiveTraditional Chinese medicine (TCM) constitutes a valuable cultural heritage and an important source of antitumor compounds. Poria (Poria cocos (Schw.) Wolf), the dried sclerotium of a polyporaceae fungus, was first documented in Shennong’s Classic of Materia Medica and has been used therapeutically and dietarily in China for millennia. Traditionally recognized for its diuretic, spleen-tonifying, and sedative properties, modern pharmacological studies confirm that Poria exhibits antioxidant, anti-inflammatory, antibacterial, and antitumor activities. Pachymic acid (PA; a triterpenoid with the chemical structure 3β-acetyloxy-16α-hydroxy-lanosta-8,24(31)-dien-21-oic acid), isolated from Poria, is a principal bioactive constituent. Emerging evidence indicates PA exerts antitumor effects through multiple mechanisms, though these remain incompletely characterized. Neuroblastoma (NB), a highly malignant pediatric extracranial solid tumor accounting for 15% of childhood cancer deaths, urgently requires safer therapeutics due to the limitations of current treatments. Although PA shows multi-mechanistic antitumor potential, its efficacy against NB remains uncharacterized. This study systematically investigated the potential molecular targets and mechanisms underlying the anti-NB effects of PA by integrating network pharmacology-based target prediction with experimental validation of multi-target interactions through molecular docking, dynamic simulations, and in vitro assays, aimed to establish a novel perspective on PA’s antitumor activity and explore its potential clinical implications for NB treatment by integrating computational predictions with biological assays. MethodsThis study employed network pharmacology to identify potential targets of PA in NB, followed by validation using molecular docking, molecular dynamics (MD) simulations, MM/PBSA free energy analysis, RT-qPCR and Western blot experiments. Network pharmacology analysis included target screening via TCMSP, GeneCards, DisGeNET, SwissTargetPrediction, SuperPred, and PharmMapper. Subsequently, potential targets were predicted by intersecting the results from these databases via Venn analysis. Following target prediction, topological analysis was performed to identify key targets using Cytoscape software. Molecular docking was conducted using AutoDock Vina, with the binding pocket defined based on crystal structures. MD simulations were performed for 100 ns using GROMACS, and RMSD, RMSF, SASA, and hydrogen bonding dynamics were analyzed. MM/PBSA calculations were carried out to estimate the binding free energy of each protein-ligand complex. In vitro validation included RT-qPCR and Western blot, with GAPDH used as an internal control. ResultsThe CCK-8 assay demonstrated a concentration-dependent inhibitory effect of PA on NB cell viability. GO analysis suggested that the anti-NB activity of PA might involve cellular response to chemical stress, vesicle lumen, and protein tyrosine kinase activity. KEGG pathway enrichment analysis suggested that the anti-NB activity of PA might involve the PI3K/AKT, MAPK, and Ras signaling pathways. Molecular docking and MD simulations revealed stable binding interactions between PA and the core target proteins AKT1, EGFR, SRC, and HSP90AA1. RT-qPCR and Western blot analyses further confirmed that PA treatment significantly decreased the mRNA and protein expression of AKT1, EGFR, and SRC while increasing the HSP90AA1 mRNA and protein levels. ConclusionIt was suggested that PA may exert its anti-NB effects by inhibiting AKT1, EGFR, and SRC expression, potentially modulating the PI3K/AKT signaling pathway. These findings provide crucial evidence supporting PA’s development as a therapeutic candidate for NB.
2.Loss-of-function CFTR p.G970D missense mutation might cause congenital bilateral absence of the vas deferens and be associated with impaired spermatogenesis.
Jian-Wen HOU ; Xiao-Liang LI ; Li WANG ; Cong-Ling DAI ; Na LI ; Xiao-Hui JIANG ; Yue-Qiu TAN ; Er-Po TIAN ; Qin-Tong LI ; Wen-Ming XU
Asian Journal of Andrology 2023;25(1):58-65
Congenital bilateral absence of the vas deferens (CBAVD) is observed in 1%-2% of males presenting with infertility and is clearly associated with cystic fibrosis transmembrane conductance regulator (CFTR) mutations. CFTR is one of the most well-known genes related to male fertility. The frequency of CFTR mutations or impaired CFTR expression is increased in men with nonobstructive azoospermia (NOA). CFTR mutations are highly polymorphic and have established ethnic specificity. Compared with F508Del in Caucasians, the p.G970D mutation is reported to be the most frequent CFTR mutation in Chinese patients with cystic fibrosis. However, whether p.G970D participates in male infertility remains unknown. Herein, a loss-of-function CFTR p.G970D missense mutation was identified in a patient with CBAVD and NOA. Subsequent retrospective analysis of 122 Chinese patients with CBAVD showed that the mutation is a common pathogenic mutation (4.1%, 5/122), excluding polymorphic sites. Furthermore, we generated model cell lines derived from mouse testes harboring the homozygous Cftr p.G965D mutation equivalent to the CFTR variant in patients. The Cftr p.G965D mutation may be lethal in spermatogonial stem cells and spermatogonia and affect the proliferation of spermatocytes and Sertoli cells. In spermatocyte GC-2(spd)ts (GC2) Cftr p.G965D cells, RNA splicing variants were detected and CFTR expression decreased, which may contribute to the phenotypes associated with impaired spermatogenesis. Thus, this study indicated that the CFTR p.G970D missense mutation might be a pathogenic mutation for CBAVD in Chinese males and associated with impaired spermatogenesis by affecting the proliferation of germ cells.
Humans
;
Animals
;
Mice
;
Male
;
Mutation, Missense
;
Retrospective Studies
;
Cystic Fibrosis Transmembrane Conductance Regulator/genetics*
;
Infertility, Male/genetics*
;
Mutation
;
Vas Deferens/abnormalities*
;
Spermatogenesis/genetics*
3.Multi-omics research contributes to early screening, diagnosis and treatment of liver cancer.
Wen Cong DAI ; Rong FAN ; Ai Hua SUN ; Fu Chu HE ; Jin Lin HOU
Chinese Journal of Hepatology 2022;30(8):793-796
In 2016, the World Health Organization set an ambitious goal of reducing viral hepatitis-related deaths by 65% by 2030. The key to this goal is to reduce viral hepatitis-related HCC deaths. Liver cancer is the fourth most common malignant tumor and the second leading cause of cancer death in China. The onset of HCC is insidious, and most patients are already in the middle and late stage when diagnosed. Despite the great progress on management of HCC, the therapeutic effect and prognosis of HCC are still unsatisfactory. Therefore, multi-dimensional and comprehensive analysis of the mechanism of liver cancer, improving the early screening, diagnosis and treatment rate of liver cancer are the key points of reducing the harm of liver cancer in China. In recent years, multi-omics studies have been widely applied in the field of liver cancer, providing a basis for the pathogenesis of liver cancer, early detection and diagnosis, development of individual treatment strategies and prognosis assessment. This issue will focus on the application of genomics, proteomics, metabolomics and imaging omics in early screening, diagnosis and treatment of liver cancer.
Carcinoma, Hepatocellular/therapy*
;
Early Detection of Cancer/methods*
;
Hepatitis, Viral, Human
;
Humans
;
Liver Neoplasms/therapy*
;
Prognosis
4.Research advances of metabolomics in early diagnosis of hepatocellular carcinoma.
Xing Mei LIAO ; Si Ru ZHAO ; Wen Cong DAI ; Rong FAN
Chinese Journal of Hepatology 2022;30(8):803-808
Primary liver cancer is the second leading cause of death from malignant tumors in China, and hepatocellular carcinoma (HCC) is the main type. The disease stage at the time of HCC diagnosis largely determines the efficacy of subsequent treatment. Due to the HCC screening among high-risk population has not yet popularized, and the current diagnose method of early HCC is not satisfactory, the early HCC diagnosis rate is less than 30% in China. Metabolomics research emerging in recent years has promoted the research progress of HCC in many fields, such as elaborating the mechanism of occurrence and development, early prevention and diagnosis, exploring drug treatment targets. At the same time, a large number of serum metabolites with excellent sensitivity and specificity were discovered, which made up for the deficiency of traditional serological indicators and helped the early screening and early diagnosis of HCC. This review will summarize the studies on serum metabolomic markers of HCC in recent 5 years, explore the role of metabolomics in the early prediction and diagnosis of HCC and its application prospect.
Biomarkers, Tumor
;
Carcinoma, Hepatocellular/pathology*
;
Early Detection of Cancer
;
Humans
;
Liver Neoplasms/pathology*
;
Metabolomics/methods*
5.Automated Pre-delineation of CTV in Patients with Cervical Cancer Using Dense V-Net.
Wen GUO ; Zhongjian JU ; Wei YANG ; Shanshan GU ; Jin ZHOU ; Xiaohu CONG ; Jie LIU ; Xiangkun DAI
Chinese Journal of Medical Instrumentation 2020;44(5):409-414
We use a dense and fully connected convolutional network with good feature learning in small samples, to automatically pre-deline CTV of cervical cancer patients based on CT images and evaluate the effect. The CT data of stage IB and IIA postoperative cervical cancer with similar delineation scope were selected to be used to evaluate the pre-sketching accuracy from three aspects:sketching similarity, sketching offset and sketching volume difference. It has been proved that the 8 most representative parameters are superior to those with single network and reported internationally before. Dense V-Net can accurately predict CTV pre-delineation of cervical cancer patients, which can be used clinically after simple modification by doctors.
Automation
;
Female
;
Humans
;
Machine Learning
;
Patients
;
Tomography, X-Ray Computed
;
Uterine Cervical Neoplasms/diagnostic imaging*
6.Design, synthesis, and biological evaluation of novel nitric oxide releasing dehydroandrographolide derivatives.
Lin YAN ; Yu-Xuan DAI ; Guo-Long GU ; Miao-Bo PAN ; Shuai-Cong WU ; Yu CAO ; Wen-Long HUANG
Chinese Journal of Natural Medicines (English Ed.) 2018;16(10):782-790
A series of new hybrids of dehydroandrographolide (TAD), a biologically active natural product, bearing nitric oxide (NO)-releasing moieties were synthesized and designated as NO-donor dehydroandrographolide. The biological activities of target compounds were studied in human erythroleukemia K562 cells and breast cancer MCF-7 cells. Biological evaluation indicated that the most active compound I-5 produced high levels of NO and inhibited the proliferation of K562 (IC 1.55 μmol·L) and MCF-7 (IC 2.91 μmol·L) cells, which were more potent than the lead compound TAD and attenuated by an NO scavenger. In conclusion, I-5 is a novel hybrid with potent antitumor activity and may become a promising candidate for future intensive study.
Antineoplastic Agents
;
chemical synthesis
;
chemistry
;
Cell Proliferation
;
drug effects
;
Diterpenes
;
chemistry
;
pharmacology
;
Drug Design
;
Drug Screening Assays, Antitumor
;
Humans
;
K562 Cells
;
MCF-7 Cells
;
Nitric Oxide
;
chemistry
;
pharmacology
;
Structure-Activity Relationship
7.Xanthogranuloma of the Sellar Region.
Cong-Xin DAI ; Xiao-Shuang GUO ; Xiao-Hai LIU ; Xin-Jie BAO ; Ming FENG ; Ding-Rong ZHONG ; Wen-Bin MA ; Ren-Zhi WANG ; Yong YAO
Chinese Medical Journal 2017;130(2):249-250
8.Suppress Sampling Truncation Artifacts in Constant-time Type Nuclear Magnetic Resonance Experiments Using Iterative Soft Thresholding Method
Bin JIANG ; Min Xiao HE ; Huang Yun YANG ; Xu ZHANG ; Xin ZHOU ; Gang Cong LI ; Wen Dai YANG ; li Mai LIU
Chinese Journal of Analytical Chemistry 2017;45(12):1888-1894
Sampling truncation, i. e. sampling ends before signal decays to zero, introduces wiggle-like artifacts that impair the quality of nuclear magnetic resonance ( NMR) spectra. In multidimensional ( mD) NMR experiments, the first few hundred or less data points are commonly sampled in the indirect dimension, and the truncation is unavoidable. Apodization can suppress truncation artifacts with cost of line-broadening. Linear prediction is also beneficial to the reduction of truncation artifacts. The worst situation is in the constant time ( CT) type experiments, where the signal doesn ' t decay at all in the CT evolution dimension. In this contribution we proposed that, although iterative soft thresholding ( IST) was rarely used due to the difficult parameter tuning, it was particularly suitable to suppress the truncation artifacts in the CT type NMR experiments. The simulation and experiments were performed to show the performance of this method. And the processing result was compared with a method proposed recently.
9.Induce effect of iodinated contrast media on necrosis of human renal tubular epithelial cell
Xiao-Feng GUAN ; Qing-Jie CHEN ; Wen-Jun YIN ; Dai-Yang LI ; Jiang-Lin WANG ; Xiao-Cong ZUO
The Chinese Journal of Clinical Pharmacology 2017;33(3):248-250
Objective To explore the effection necrosis of human renal tubular epithelial (HK-2) cell induced by iodinated contrast media.Methods The HK-2 cell was cultured in vitro.The experiment was divided into three groups:control group,iohexol group,urografin group.HK-2 cell was treated with iohexol(75 mgI · mL-1) and urografin(75 mgI · mL-1).Cell vitality was determined by MrTF assay at time of 2 h after intervention and of 5,22 h after drug removal.The release of lactate dehydrogenase (LDH) in liquid supernatant was detected by using LDH kit.Quantitative analysis of Hoechst33342/PI staining results was carried out by high content imaging system.Apoptosis rate and death rate were calculated.Results Compared with the control group,iohexol and urografin induced the cell vitality decreased to (52.98 ± 6.75)%,(47.16 ±4.18)% at time of 2 h after intervention with statistically significant (P < 0.01).And the release of LDH increased to (201.31 ± 11.69),(256.21 ± 19.82) U · L-1 with statistically significant (P <0.01).This effect still existed at 5 h and 22 h after the drugs removed.The apoptosis rates of iohexol and urografin were (23.09 ± 4.25) %,(38.64 ± 8.32) %;the necrosis rates of iohexol and urografin were(19.69 ± 2.13) %,(24.07 ± 6.18) %,which increased significantly compared with the control group (P < 0.01).Moreover,urografin induced HK-2 cell necrosis more significantly (P < 0.05).Conclusion Iodinated contrast media can induce necrosis of human renal tubular epithelial cell.
10.Analysis of urinary iodine level of children aged 8-10 years in Yunyang and Bishan County of Chongqing in 2007
Ya, YU ; Li-hong, MU ; Xing-bi, DAI ; Ge, LI ; Wen-fang, LIAO ; Xin-shu, LI ; Yong, ZHANG ; Jian-ni, CONG
Chinese Journal of Endemiology 2009;28(3):315-318
Objective To determine the urinary iodine level of people in Yunyang and Bishan County of Chongqing and explore into its influencing factors. Methods Using multistage cluster stratified simple random sample method, Yunyang and Bishan County were chosen as research spots, then thirty children aged 8-10 in each 3 primary school of the 2 counties were selected using stratified randomization sampling method to inspected their urine and household salt for iodine and the iodine content in drinking water. Results Five hundred and seventy-one urine samples were inspected and the urinary iodine median was 261.47 μg/L. 5.78% (33/571) and 37.48%(214/571) of samples had an urinary iodine median less than 100 μg/L and more than 300 μg/L. The urinary iodine median of Yunyang County was higher than that of Bishan (H = 7.42, P < 0.01). The iodine salt coverage rate, the qualified rate and edible qualified iodine salt rate respectively were 99.64%(554/556), 94.22% (522/554) and 93.88% (522/556) in 556 samples of family table salt. Eighty-seven samples of drinking water were inspected, resulting an averaged iodine content of 8.81 and 2.97 μg/L, respectively in the 2 counties. Conclusions The 2 counties are all the area of iodine deficiency. The urinary iodine level, although meeting the demand of eliminating iodine deficiency diseases, is a little bit higher given that iodized salt of present doage has been taken for a long time. The content of iodized salt should be adjusted accordingly.

Result Analysis
Print
Save
E-mail